Natural psychedelics drug developer Filament Health Corp. (OTCQB: FLHLF) shared its interim financial results and further business highlights for the first quarter ended March 31, 2023.
These results were assembled by the company’s management and were not reviewed by the independent auditor as of May 12 and reportedly “do not include all the information and notes required by International Financial Reporting Standards (IFRS) for annual financial statements.”
Further, the filing’s Note 1 describes “the material uncertainty that may cast significant doubt on the company’s ability to continue as an ongoing concern.”
See also: Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
Numbers for the quarter ended March 31, including …